Page last updated: 2024-08-21

arsenic trioxide and EBV Infections

arsenic trioxide has been researched along with EBV Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Block, GJ; Chadwick, RW; Flemington, EK; Lasky, JA; Shan, B; Sides, MD	1

Other Studies

1 other study(ies) available for arsenic trioxide and EBV Infections

Article	Year
Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies. Virology journal, 2011, Oct-05, Volume: 8 Topics: Arsenic Trioxide; Arsenicals; beta-Galactosidase; Cell Line; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Viral; Gene Silencing; Genes, Reporter; Herpesvirus 4, Human; Humans; Intranuclear Inclusion Bodies; Leukemia, Promyelocytic, Acute; Luciferases; Nuclear Proteins; Oxides; Plasmids; Promyelocytic Leukemia Protein; RNA, Small Interfering; Transcription Factors; Transcription, Genetic; Transfection; Tumor Suppressor Proteins; Viral Matrix Proteins	2011

Article

Year

Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.

Virology journal, 2011, Oct-05, Volume: 8

Topics: Arsenic Trioxide; Arsenicals; beta-Galactosidase; Cell Line; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Viral; Gene Silencing; Genes, Reporter; Herpesvirus 4, Human; Humans; Intranuclear Inclusion Bodies; Leukemia, Promyelocytic, Acute; Luciferases; Nuclear Proteins; Oxides; Plasmids; Promyelocytic Leukemia Protein; RNA, Small Interfering; Transcription Factors; Transcription, Genetic; Transfection; Tumor Suppressor Proteins; Viral Matrix Proteins

2011